Business Wire

CA-ANDERSEN-GLOBAL

9.7.2020 12:36:12 CEST | Business Wire | Pressemeddelelse

Del
Andersen befæster sin tilstedeværelse i Europa

Efter at have opereret under navnene Andersen Tax, Andersen Legal og Andersen Tax & Legal vil medlemmerne af Andersen Global i Europa nu operere under et enkelt brand: ”Andersen”, hvilket viser det globale skatte- og advokatfirmas harmoniserede og homogene tilgang. Der vil ske lignende brandændringer i andre regioner rundt om i verden året igennem.

Denne bekendtgørelse kommer i hælene på de amerikanske medlemsfirmaers overgang til brandet ”Andersen” fra ”Andersen Tax” sidste år. I alt vil medlemsfirmaer i 12 europæiske lande – Cypern, Tyskland, Grækenland, Ungarn, Irland, Italien, Luxembourg, Polen, Portugal, Spanien, Schweitz og Storbritannien – tage Andersen-brandet til sig. Overgangen af OrienTax og Szabo Keleman & Partners markerer introduktionen af Andersen-brandet i Ungarn. Derudover vil B.A Tax Accountants tage brandet til sig, når de bliver en del af teamet i Luxembourg.

Inden for Europa er Andersen Global også til stede i Østrig, Bosnien og Herzegovina, Bulgarien, Kroatien, Kazakhstan, Moldova, Nederlandene, Nordmakedonien, Republikken Kosovo, Rumænien, Serbien, Slovakiet, Slovenien og Ukraine gennem sine samarbejdende firmaer og har planer om i fremtiden at udvide sit regionale fodaftryk i Central- og Østeuropa samt Skandinavien.

Optagelsen af Andersen-brandet i Europa er den bedste repræsentant for den komplette pakke af tjenester, som organisationen tilbyder sine kunder internationalt, inkl. juridiske tjenester i 86 lande, hvoraf 23 er i Europa.

”Vores fælles brand, Andersen, afspejler vores »én samlet virksomhed«-kultur og omfatter alt, hvad vi foretager os som en global organisation. Det kendetegner vores evne til at levere den bedste service indenfor branchen og vores dybe engagement i investering i vores folk,” siger Mark Vorsatz, formand for Andersen Global og administrerende direktør i Andersen. ”Hvert eneste medlem og samarbejdende firma, der er del af vores organisation, fremmer forvaltning og bibeholder gennemsigtighed. Vores globale organisation fortsætter med at været drevet af kunders behov og erkendelsen af, at vi bedst servicerer vores kunder med uafhængige og sammenhængende tjenester.”

Overgangen til Andersen-brandet i Europa er en milepæl for den globale organisation, som tog sin begyndelse i 2002, da 23 forhenværende Arthur Andersen skattepartnere skabte skattefirmaet WTAS. I 2014 tog gruppen brandet Andersen Tax til sig, da det bedst repræsenterede firmaets værdier, kunden først- kultur, forvaltning og gennemsigtighed. Organisationen er vokset eksponentielt siden etableringen af Andersen Global (tidligere WTAS Global) af det amerikanske grundlæggermedlem Andersen Tax LLC i 2013. Den europæiske region begyndte med kun to steder i 2013 og er siden vokset til mere end 50 steder, med flere end 2.000 skatte- og juridiske rådgivere og flere end 300 partnere i dag.

”Mange lande og regioner, såsom Storbritannien, presser på for at revisionsfirmaer adskiller deres revisions- og skattepraksis for at sikre integritet og uafhængighed,” siger Paolo Mondia, Co-Regional Managing Director in Europa. ”Vi har et konkurrencemæssigt forspring på det europæiske marked, hvor kombinerede skatte- og juridiske tjenester på uafhængig vis hører til undtagelsen, og vores kunder har været ekstremt modtagelige overfor denne model.”

Andrea De Vecchi, Co-Regional Managing Director in Europe, tilføjer: ”Ved at yde både juridiske og skattemæssige tjenester har vi været i stand til at udvide vores regionale og globale fodaftryk, forbedre vores serviceudbud og få fordelene og ressourcerne fra et globalt firma til vores kunder på en gnidningsfri måde.”

Gennem hele 2020 medlemsfirmaer over hele verden vil optage Andersen-brandet, mens den globale organisation vil fortsætte med at give mere dybde på afgørende markeder, herunder Afrika og Mellemøsten. Det er visionen at udvikle en gnidningsfri, professionel tjenestemodel med den bedste service i branchen rundt om i verden.

Andersen Global er en international sammenslutning af juridisk separate, uafhængige medlemsfirmaer, bestående af skatte- og juraeksperter fra hele verden. Siden oprettelsen i 2013 af det amerikanske medlemsfirma Andersen Tax LLC har Andersen Global nu over 5.000 eksperter globalt og er repræsenteret på over 177 lokaliteter via sine medlems- og samarbejdsfirmaer.

Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release

REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release

In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release

- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release

Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye